Global Lung Cancer Therapeutics Market 2016-2020
- SKU ID : TNV-IRTNTR10849 10366351
- |
- Publishing Date: 18-Nov-2016
- |
- Region: Global
- |
- No. of pages: 101
About Lung Cancer Therapeutics
Lung cancer is a common cause of mortality and morbidity in both developed and developing countries. Smoking is a major cause of lung cancer, though it also occurs in non-smokers. Lung cancer can be categorized into two major types, namely NSCLC and SCLC. NSCLC is the commonest type of lung cancer and constitutes almost 85%-90% of the total diagnosed cases. It grows and spreads quite slowly.
Technavio’s analysts forecast the global lung cancer therapeutics market to contribute around $11.19 billion during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global lung cancer therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded and generic drugs used to treat and prevent lung cancer therapeutics. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the genericization of the marketed drugs during the forecast period.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Lung Cancer Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• F. Hofmann-La Roche
• Eli Lilly
• AstraZeneca
• Pfizer
• Celgene
Other prominent vendors
• Abbvie
• Aetna
• Agennix
• Allergan
• Amgen
• ARIAD Pharmaceuticals
• Astellas Pharma
• Betta Pharmaceuticals
• BeyondSpring Pharmaceuticals
• BioNumerik Pharmaceuticals
• Boehringer Ingelheim
• Boston Biomedical
• Bristol-Myers Squibb
• Celldex
• CTI BioPharma
• Eisai
• GlaxoSmithKline
• GTx
• Helsinn
• Hutchison Medipharma
• Ionis Pharmaceuticals
• Kadmon Corporation
• MabVax
• Merck
• Novartis
• NovaRx Corporation
• OncoGeneX
• Ono Pharmaceutical
• OSE Immunotherapeutics
• OSI Pharmaceuticals
• Peregrine
• PharmaMar
• Pierre Fabre
• Qiagen
• Recombio
• Samsung Bioepis
• Sanofi
• SFJ Pharmaceuticals
• Spectrum Pharmaceuticals
• Sumitomo Dainippon Pharma
• Synta
• Takeda Pharmaceuticals
• Teva Pharmaceutical
• Xcovery
Market driver
• Growing demand for targeted therapies
• For a full, detailed list, view our report
Market challenge
• Growing popularity of alternative therapeutics
• For a full, detailed list, view our report
Market trend
• Emergence of nanomedicine platform for the treatment of lung cancer
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Lung cancer is a common cause of mortality and morbidity in both developed and developing countries. Smoking is a major cause of lung cancer, though it also occurs in non-smokers. Lung cancer can be categorized into two major types, namely NSCLC and SCLC. NSCLC is the commonest type of lung cancer and constitutes almost 85%-90% of the total diagnosed cases. It grows and spreads quite slowly.
Technavio’s analysts forecast the global lung cancer therapeutics market to contribute around $11.19 billion during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global lung cancer therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded and generic drugs used to treat and prevent lung cancer therapeutics. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the genericization of the marketed drugs during the forecast period.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Lung Cancer Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• F. Hofmann-La Roche
• Eli Lilly
• AstraZeneca
• Pfizer
• Celgene
Other prominent vendors
• Abbvie
• Aetna
• Agennix
• Allergan
• Amgen
• ARIAD Pharmaceuticals
• Astellas Pharma
• Betta Pharmaceuticals
• BeyondSpring Pharmaceuticals
• BioNumerik Pharmaceuticals
• Boehringer Ingelheim
• Boston Biomedical
• Bristol-Myers Squibb
• Celldex
• CTI BioPharma
• Eisai
• GlaxoSmithKline
• GTx
• Helsinn
• Hutchison Medipharma
• Ionis Pharmaceuticals
• Kadmon Corporation
• MabVax
• Merck
• Novartis
• NovaRx Corporation
• OncoGeneX
• Ono Pharmaceutical
• OSE Immunotherapeutics
• OSI Pharmaceuticals
• Peregrine
• PharmaMar
• Pierre Fabre
• Qiagen
• Recombio
• Samsung Bioepis
• Sanofi
• SFJ Pharmaceuticals
• Spectrum Pharmaceuticals
• Sumitomo Dainippon Pharma
• Synta
• Takeda Pharmaceuticals
• Teva Pharmaceutical
• Xcovery
Market driver
• Growing demand for targeted therapies
• For a full, detailed list, view our report
Market challenge
• Growing popularity of alternative therapeutics
• For a full, detailed list, view our report
Market trend
• Emergence of nanomedicine platform for the treatment of lung cancer
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
